Cargando…

Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature

Different treatment protocols have been employed to manage heparin/low-dose aspirin refractory or high-risk pregnancies in antiphospholipid antibody syndrome (APS) pregnancies. A systematic review of the literature on additional treatments used in refractory and/or high-risk APS pregnancies was cond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoxha, Ariela, Tormene, Daniela, Campello, Elena, Simioni, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160870/ https://www.ncbi.nlm.nih.gov/pubmed/35662738 http://dx.doi.org/10.3389/fphar.2022.849692

Ejemplares similares

The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study
por: Tormene, Daniela, et al.
Publicado: (2021)

Perioperative management of patients with antiphospholipid and catastrophic antiphospholipid syndrome undergoing urgent neurosurgery
por: Ginosyan, Knarik, et al.
Publicado: (2023)

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
por: Poletto, Francesco, et al.
Publicado: (2022)

Prevalence and adverse consequences of delayed diagnosis and misdiagnosis in thrombotic antiphospholipid syndrome. An observational cohort study and a review of the literature
por: Ruffatti, Amelia, et al.
Publicado: (2023)

Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022)

Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome
por: Niznik, Stanley, et al.
Publicado: (2022)

Immunomodulation in the Treatment of Refractory Catastrophic Antiphospholipid Syndrome
por: Nath, Karthik, et al.
Publicado: (2018)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Management of Women with Antiphospholipid Antibodies or Antiphospholipid Syndrome during Pregnancy
por: Lee, Eunyoung Emily, et al.
Publicado: (2021)

Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome
por: Killian, Martin, et al.
Publicado: (2022)

Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature
por: Hoxha, Ariela, et al.
Publicado: (2023)

Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19
por: Campello, Elena, et al.
Publicado: (2022)

POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience
por: Simion, Chiara, et al.
Publicado: (2022)

Research trends and frontiers on antiphospholipid syndrome: A 10-year bibliometric analysis (2012–2021)
por: Wu, Teng, et al.
Publicado: (2022)

Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome
por: Velásquez, Manuela, et al.
Publicado: (2021)

Catastrophic antiphospholipid syndrome during pregnancy
por: Fuentes Carrasco, Marta, et al.
Publicado: (2021)

A Case of Microangiopathic Antiphospholipid-Associated Syndromes during Pregnancy: Review of the Literature
por: Suzumori, Nobuhiro, et al.
Publicado: (2012)

A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding
por: Lim, William, et al.
Publicado: (2021)

Primary Refractory Catastrophic Antiphospholipid Syndrome Masquerading as Buerger’s Disease
por: Tannous, Toufic, et al.
Publicado: (2021)

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study
por: Campello, Elena, et al.
Publicado: (2020)

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
por: Campello, Elena, et al.
Publicado: (2021)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
por: Campello, Elena, et al.
Publicado: (2022)

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Liu, Yadan, et al.
Publicado: (2021)

Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
por: Spiezia, Luca, et al.
Publicado: (2023)

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review
por: Pires da Rosa, Gilberto, et al.
Publicado: (2022)

Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis
por: Mialdea, Maria, et al.
Publicado: (2009)

Clinical Report of Probable Catastrophic Antiphospholipid Syndrome in Pregnancy
por: Hakman, Eryk, et al.
Publicado: (2018)

Antiphospholipid Syndrome and Preeclampsia in Pregnancy: A Case Report
por: Skoura, Rafailia, et al.
Publicado: (2022)

Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms
por: D’Ippolito, Silvia, et al.
Publicado: (2023)

Pregnancy outcomes in patients with primary antiphospholipid syndrome: A systematic review and meta-analysis
por: Liu, Liping, et al.
Publicado: (2019)

25. Use of rituximab in refractory primary antiphospholipid syndrome with pulmonary and cerebral manifestations
por: Khan, Asim, et al.
Publicado: (2019)

Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome
por: Al-Khateeb, Mashael, et al.
Publicado: (2019)

Chorea Associated with High Titers of Antiphospholipid Antibodies in the Absence of Antiphospholipid Antibody Syndrome
por: Safarpour, Damoun, et al.
Publicado: (2015)

Cardiovascular Risk Factors in the Antiphospholipid Syndrome
por: da Silva, Felipe Freire, et al.
Publicado: (2014)

Risk of abnormal pregnancy outcomes after using ondansetron during pregnancy: A systematic review and meta-analysis
por: Cao, Xiao, et al.
Publicado: (2022)

Hemorrhage complications in obstetric antiphospholipid syndrome: Risk factors and association with adverse pregnancy outcomes
por: Luo, Yongjing, et al.
Publicado: (2023)

Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003)

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)

Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
por: Baños, Núria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hgv056l104pef03kntg8phr1sk